Intrinsiqs

Is Damora Therapeutics, Inc. overvalued?

Damora Therapeutics, Inc. (DMRA) — key valuation metrics and fundamentals.

No verdict
Price
$21.60
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$1.34B
Dividend yield
0.0%
Return on equity
-66.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares DMRA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.